“…Benefits have been demonstrated in patients with chronic pain syndromes (Fregni et al, 2006; Fenton et al, 2009; Fagerlund et al, 2015) and neuropsychiatric conditions (Baker et al, 2010; Loo et al, 2012; Palm et al, 2012; Kaski et al, 2014; Bandeira et al, 2016; Breitling et al, 2016), whilst in the healthy population, there is increasing scientific interest in the motor enhancing properties of the technology. Aligning with this trend, an increasing number of commercial companies (Edwards et al, 2017) promote the augmentation of motor abilities with tDCS including greater muscular power output (Okano et al, 2015; Huang et al, 2019), longer athletic endurance (Vitor-Costa et al, 2015; Park et al, 2019) and improved posture and balance (Kaminski et al, 2016; Saruco et al, 2017). This arena is most commonly explored through anodal tDCS to the primary motor cortex (M1), although the precise mechanism of action remains a matter of debate (Giordano et al, 2017).…”